Smith Asset Management Group »

Heron Therapeutics shares owned by Smith Asset Management Group

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Smith Asset Management Group from 13F filings

Historical chart of Smith Asset Management Group investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Smith Asset Management Group

Quarter filed Position value Share count Share price at filing
2021-06-30 $2.0k 120 16.67
2021-03-31 $2.0k 120 16.67
2020-12-31 $79k 3.7k 21.24
2020-09-30 $55k 3.7k 14.78
2020-06-30 $41k 2.8k 14.59
2020-03-31 $33k 2.8k 11.62
2019-12-31 $67k 2.8k 23.59
2019-09-30 $53k 2.8k 18.66
2019-06-30 $43k 2.3k 18.61
2019-03-31 $56k 2.3k 24.24
2018-12-31 $231k 8.9k 25.93
2018-09-30 $282k 8.9k 31.65